发明名称 THERAPEUTIC AGENT FOR IMPAIRED GLUCOSE TOLERANCE CONTAINING PIOGLITAZONE
摘要 PROBLEM TO BE SOLVED: To obtain a therapeutic agent for impaired glucose tolerance effective in preventing and delaying the onset of non-insulin-dependent type diabetes mellitus(NIDDM) by including pioglitazone. SOLUTION: This therapeutic agent is obtained by including pioglitazone 5-[4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl]thiazolidine-2,4-dione}. In addition to the above compound, the inclusion of even a compound represented by formula I (R1 and R2 are each H or a 1-5C alkyl; R3 is H, a 1-6C aliphatic acyl or the like; R4 and R5 are each H, a 1-5C alkoxy or the like; n is 1-3; W is CH2 or the like; Y and Z are each O or imino), formula II [R11 is a (substituted)alkyl, a (substituted)alkoxy or the like; L1 and L2 are each H, a lower alkyl or the like], formula III (R15 and R16 are each H, a 1-6C alkyl, a 1-6C alkoxy or the like; n is 0-4) or formula IV (the dotted line is bonded or unbonded; V is CH=C or the like; D is CHOH or the like; X is CH or N; Z is H, phenyl or the like; Z is H or the like; n is 1-3) is effective in preventing or delaying the onset of NIDDM.
申请公布号 JP2000273043(A) 申请公布日期 2000.10.03
申请号 JP20000071977 申请日期 2000.03.15
申请人 SANKYO CO LTD 发明人 OLEFSKY JERROLD;ANTONUCCI TAMMY;LOCKWOOD DEAN;NORRIS REBECCA
分类号 C07D277/20;A61K31/41;A61K31/42;A61K31/421;A61K31/423;A61K31/425;A61K31/426;A61K31/427;A61K31/44;A61K31/4439;A61K31/495;A61K31/505;A61P3/06;A61P3/08;A61P3/10;A61P5/50;A61P9/12;A61P13/02;A61P15/00;A61P25/02;A61P43/00;C07D263/44;C07D263/56;C07D277/34;C07D291/04;C07D413/14;C07D417/06;C07D417/10;C07D417/12;(IPC1-7):A61K31/443 主分类号 C07D277/20
代理机构 代理人
主权项
地址